SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.

NCT05461170 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis D, Chronic

Interventions

DRUG: VIR-2218
DRUG: VIR-3434
DRUG: NRTI

Sponsor

Vir Biotechnology, Inc.